Don’t miss out
as we share valuable insights into optimising CMC product development,
characterisation, and risk management, all designed to deliver high-quality
materials that meet the toughest clinical and regulatory requirements.
Key topics covered
- High-quality
API production:
How Bachem ensures the development of top-tier peptide and oligonucleotide
APIs.
- Risk
mitigation strategies: Managing and reducing
process-related risks to enhance product stability and
compliance.
-
Meeting regulatory and clinical timelines: Aligning
process development with evolving industry guidelines and approval
pathways.
-
Comprehensive CMC development concept: A flexible
approach tailored to the unique needs of each product.
What you’ll gain from the CMC development webinar
- In-depth
risk analysis:
Learn how we assess and address potential risks in CMC manufacturing
control.
- Efficient
development strategies: Explore how our approach
accelerates characterisation and risk management in CMC chemistry
manufacturing and controls.
-
Quality-driven outcomes: Understand how we deliver the
best-quality material for preclinical, clinical, and commercial supply
through CMC pharmaceutical processes.
-
Expert insights: Gain first-hand knowledge from
experienced industry leaders in CMC pharmaceutical development.
